The Center for Pain Management is First in Georgia to Offer New Treatment Option for Chronic Pain
Plano, Texas (PRWEB) May 11, 2017 -- Nuvectra Corporation is pleased to announce that Kamal Kabakibou, MD is the first physician in Georgia to implant the Algovita® Spinal Cord Stimulation System, a powerfully versatile, patient-centric spinal cord stimulation system. The Algovita SCS System has been FDA approved as a treatment option for chronic intractable pain.
“The uniqueness of the stretchability of the leads helps prevent lead migration. The steerability of the leads make the system user friendly. Additionally, the broad parametric range helps my patients obtain coverage for better pain relief,” said Dr. Kabakibou regarding the Nuvectra Algovita system.
Chronic pain affects over 100 million Americans according to the Institute of Medicine, more than diabetes, cancer, and heart disease combined. Chronic pain is difficult to treat, but one potential treatment option is spinal cord stimulation, or SCS. SCS works by masking or interrupting pain signals as they travel up the spinal cord to the brain. A small, rechargeable battery is implanted under the patient’s skin and connected to thin wires, called leads, which stimulate the nerves sending pain signals. The stimulation “overrides” the pain signals, and instead of feeling pain, patients may feel a tingling sensation known as paresthesia.
The Algovita SCS System is a new offering to the SCS market, featuring 24 current sources and the broadest overall set of parametric ranges offered for tonic SCS. This combination provides flexible coverage and expanded programming options for individualized patient therapy. Algovita also offers the industry’s only stretchable leads, which are designed to reduce the risk of lead fracture and migration. In addition, the system’s percutaneous leads feature up to 12 contacts for wide coverage of potential pain areas. The Algovita system was designed to be patient-centric and easy to use. The wireless Pocket Programmer fits discreetly in a hand, purse, or pocket and allows a patient to conveniently adjust their therapy on the go.
For more information about Nuvectra and the Algovita Spinal Cord Stimulation system, visit http://www.nuvectramed.com.
Jennifer Armstrong, Nuvectra Corporation, http://www.nuvectramed.com, +1 (214) 474-3110, [email protected]
Share this article